Please use this identifier to cite or link to this item:
|Title:||Risk of second cancer among women with breast cancer||Authors:||Mellemkjær, L.
|Keywords:||Female breast cancer
Multicentre cohort study
Second primary cancer
|Issue Date:||1-May-2006||Citation:||Mellemkjær, L., Friis, S., Olsen, J.H., Scélo, G., Hemminki, K., Tracey, E., Andersen, A., Brewster, D.H., Pukkala, E., McBride, M.L., Kliewer, E.V., Tonita, J.M., Kee-Seng, C., Pompe-Kirn, V., Martos, C., Jonasson, J.G., Boffetta, P., Brennan, P. (2006-05-01). Risk of second cancer among women with breast cancer. International Journal of Cancer 118 (9) : 2285-2292. ScholarBank@NUS Repository. https://doi.org/10.1002/ijc.21651||Abstract:||A large number of women survive a diagnosis of breast cancer. Knowledge of their risk of developing a new primary cancer is important not only in relation to potential side effects of their cancer treatment, but also in relation to the possibility of shared etiology with other types of cancer. A cohort of 525,527 women with primary breast cancer was identified from 13 population-based cancer registries in Europe, Canada, Australia and Singapore, and followed for second primary cancers within the period 1943-2000. We used cancer incidence rates of first primary cancer for the calculation of standardized incidence ratios (SIRs) of second primary cancer. Risk of second primary breast cancer after various types of nonbreast cancer was also computed. For all second cancer sites combined, except contralateral breast cancer, we found a SIR of 1.25 (95% CI = 1.24-1.26) on the basis of 31,399 observed cases after first primary breast cancer. The overall risk increased with increasing time since breast cancer diagnosis and decreased by increasing age at breast cancer diagnosis. There were significant excesses of many different cancer sites; among these the excess was larger than 150 cases for stomach (SIR = 1.35), colorectal (SIR = 1.22), lung (SIR = 1.24), soft tissue sarcoma (SIR = 2.25), melanoma (SIR = 1.29), non-melanoma skin (SIR = 1.58), endometrium (SIR = 1.52), ovary (SIR = 1.48), kidney (SIR = 1.27), thyroid gland (SIR = 1.62) and leukaemia (SIR = 1.52). The excess of cancer after a breast cancer diagnosis is likely to be explained by treatment for breast cancer and by shared genetic or environmental risk factors, although the general excess of cancer suggests that there may be additional explanations such as increased surveillance and general cancer susceptibility. © 2005 Wiley-Liss, Inc.||Source Title:||International Journal of Cancer||URI:||http://scholarbank.nus.edu.sg/handle/10635/109627||ISSN:||00207136||DOI:||10.1002/ijc.21651|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jul 2, 2020
WEB OF SCIENCETM
checked on Jul 2, 2020
checked on Jun 27, 2020
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.